More on AMBS.OB by Jonathan Verenger
Latest AMBS.OB Articles
-
Amarantus' LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
Wed, Apr 17 • Jason Napodano
-
Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
Thu, Apr 4 • Suresh Gupta
-
Valuing Amarantus - Where Financial Reality Meets Scientific Hope
Mon, Mar 11 • Jason Napodano
-
Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise
Fri, Mar 8 • Vineet Dutta
-
Scientific Literature Suggests Amarantus' MANF Has Big Potential
Wed, Feb 13 • Jason Napodano
-
Biotech Proper Is Overbought, Time To Look At Alternatives
Mon, Feb 4 • Austrolib
-
Stem Cell Therapy Companies: Underappreciated Outperformers
Tue, Jan 29 • Ryan's View
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Amarantus Biosciences, Inc. (AMBS.OB)
Posts on AMBS.OB by Jonathan Verenger
Exciting Field In Cure For Parkinson's
Posts on AMBS.OB by other instabloggers
Dr. Adam J. Simon Joins Amarantus BioScience, Inc. (AMBS) Board Of Advisors
Why Is Amarantus Bioscience Inc. Under Turmoil?
Amarantus BioScience, Inc. (AMBS) Licenses Memory Dx LymPro Alzheimer's Diagnostic Test